Funding Through Listing and Growth Investment in Personnel, Advertising and Research and Development
First written in FY2022. 4 of 11 entries say "Advanced", first in FY2023-Q1. Latest entry: 2026-08-14.
63 other companies' latest entry also says "Advanced".
- 2026-08-14AdvancedFinancial Results Presentation
「We anticipate investment of approximately ¥500 million in the fiscal year ending June 2027.」
The company indicated the scale of growth investment planned for the next fiscal year to develop sales partners for subscription-based services and strengthen its sales structure. - FY2026-H1RestatedAnnual report
「(7) Research and development activities Not applicable.」
The company also states that there were no research and development activities during the current interim accounting period. - FY2025No research and development activities; development investment continuesAnnual report
「Total capital expenditures and other investments for the fiscal year were ¥18.742 million, primarily comprising Raise Phase 1 secondary development costs and the acquisition of Itsuaki servers.」
Although the company states that there were no applicable research and development activities during the fiscal year, it made ¥18.742 million in capital investments, including Raise secondary development. - FY2025-H1No research and development activities during the interim periodAnnual report
「(7) Research and development activities Not applicable.」
Although total research and development expenses were disclosed for the previous fiscal year, the company states that there were no research and development activities during the current interim accounting period. - FY2024AdvancedAnnual report
「Total capital expenditures and other investments, including security deposits, for the fiscal year were ¥216.634 million, primarily comprising Raise Phase 1 development costs, office interior construction and the acquisition of equipment associated with the relocation of the head office.」
The company invested ¥216.634 million in Raise development and the relocation of its head office, and disclosed its investment in growth and its business infrastructure. Total research and development expenses were ¥1.2 million. - FY2024-Q3RestatedAnnual report
「We are engaged in research and development activities, including the development of new services. Total research and development expenses for the cumulative third quarter were ¥1.2 million.」
The company continues to disclose research and development activities, including the development of new services, and total research and development expenses of ¥1.2 million for the cumulative third quarter. - FY2024-Q2RestatedAnnual report
「We are engaged in research and development activities, including the development of new services. Total research and development expenses for the cumulative second quarter were ¥1.2 million.」
The company continues to disclose research and development activities, including the development of new services, and total research and development expenses of ¥1.2 million for the cumulative second quarter. - FY2024-Q1AdvancedAnnual report
「We are engaged in research and development activities, including the development of new services. Total research and development expenses for the cumulative first quarter were ¥1.2 million.」
The company conducted research and development activities, including the development of new services, and disclosed total research and development expenses of ¥1.2 million for the cumulative first quarter. The text does not indicate a direct connection with the use of proceeds stated at the time of listing. - FY2023-Q3RestatedAnnual report
「We were listed on the Tokyo Stock Exchange Growth Market on 28 September 2022. In connection with the listing, we issued 250,000 new shares through a paid public offering conducted using the book-building method, with 27 September 2022 as the payment date. The issue price was ¥1,800 per share, the underwriting price was ¥1,656, and the amount transferred to capital was ¥828. As a result, capital and capital surplus each increased by ¥207 million.」
The listing and funding through the public offering are reconfirmed. The company also reports increases in capital and capital surplus from the exercise of stock acquisition rights during the cumulative third quarter, but no new progress is indicated regarding the allocation of funds to growth investment. - FY2023-Q1AdvancedAnnual report
「We were listed on the Tokyo Stock Exchange Growth Market on 28 September 2022. In connection with the listing, we issued 250,000 new shares through a paid public offering conducted using the book-building method, with 27 September 2022 as the payment date. The issue price was ¥1,800 per share, the underwriting price was ¥1,656, and the amount transferred to capital was ¥828. As a result, capital and capital surplus each increased by ¥207 million.」
The company was listed on the Tokyo Stock Exchange Growth Market and raised funds through a public offering of 250,000 new shares, with total proceeds of ¥414 million. As completion of the allocation to growth investment was not indicated, this was classified as ADVANCED. - FY2022First statedAnnual report
「The funds are to be allocated to recruitment and training expenses for acquiring the personnel needed to expand the scale of our business, advertising expenses to expand our main customer base, including small and medium-sized business operators and sole proprietors, and research and development expenses for the continued development of products and services that anticipate companies’ DX needs, primarily in the SMB area.」
The company raised ¥414 million through a public offering associated with its September 2022 listing and plans to allocate the funds to growth investment.